In 2015, grants funded a range of projects from testing new drug combinations to
treat metastatic lung cancer to studying drug resistance in ovarian cancer.
Not exact matches
«Indeed, in a second tumor model of
metastatic breast
cancer, we demonstrated that mice
treated with the EphA2 - targeting paclitaxel conjugate presented nearly no
lung metastases, while a large numbers of lesions were observed in both untreated mice and in mice
treated with just paclitaxel.»
Patients with
metastatic non-small cell
lung cancer will always progress after chemotherapy, so most patients go on to be
treated with immunotherapy, a type of therapy that uses the body's immune system to fight
cancer.
Both drugs are approved for
treating metastatic melanoma, and Opdivo is also approved for squamous
lung cancer.
When William Pao was a medical oncology fellow at Memorial Sloan Kettering
Cancer Center (MSKCC) during the early 2000s, treating patients with metastatic non-small cell lung cancer (NSCLC) was rote: Every patient received the same chemotherapy re
Cancer Center (MSKCC) during the early 2000s,
treating patients with
metastatic non-small cell
lung cancer (NSCLC) was rote: Every patient received the same chemotherapy re
cancer (NSCLC) was rote: Every patient received the same chemotherapy regimen.
Other factors that increased suicide risk were being older, being widowed, refusing surgical treatment and having a difficult - to -
treat (
metastatic) type of
lung cancer.
For example, Zykadia, a drug for
metastatic lung cancer, received a «breakthrough therapy» designation that allows expedited approval based on preliminary evidence for certain drugs that
treat serious conditions.
In a study appearing in Science Translational Medicine, the researchers report they have effectively and safely employed this stem cell - targeting system in mice to
treat metastatic breast
cancer that had spread to the
lung.
Immunotherapy using checkpoint inhibitors has changed the way we
treat several aggressive
cancers such as melanoma, non-small cell
lung and head & neck
cancers, among others, with durable responses achieved in the
metastatic setting.
Cancer immunotherapy has been used successfully to treat late stage cancers such as leukaemia and metastatic melanoma, and recently used to treat mid-stage lung c
Cancer immunotherapy has been used successfully to
treat late stage
cancers such as leukaemia and
metastatic melanoma, and recently used to
treat mid-stage
lung cancercancer.
Cancer Institute research highlights include innovative studies to develop individualized approaches for treatment and prevention of lung cancer; collaboration between medical and materials science researchers to develop treatments for various types of leukemia using nanotechnology to target only cancer cells; and development of novel therapeutics to treat metastatic melanoma using an approach that regulates the processes leading to tumor develo
Cancer Institute research highlights include innovative studies to develop individualized approaches for treatment and prevention of
lung cancer; collaboration between medical and materials science researchers to develop treatments for various types of leukemia using nanotechnology to target only cancer cells; and development of novel therapeutics to treat metastatic melanoma using an approach that regulates the processes leading to tumor develo
cancer; collaboration between medical and materials science researchers to develop treatments for various types of leukemia using nanotechnology to target only
cancer cells; and development of novel therapeutics to treat metastatic melanoma using an approach that regulates the processes leading to tumor develo
cancer cells; and development of novel therapeutics to
treat metastatic melanoma using an approach that regulates the processes leading to tumor development.
Merck's
cancer drug Keytruda got the nod of U.S. regulators as a first - line drug for
treating metastatic non-small cell
lung cancer.